يعرض 141 - 160 نتائج من 18,386 نتيجة بحث عن '(( 50 a decrease ) OR ((( 50 n decrease ) OR ((( 10 ng decrease ) OR ( 50 we decrease ))))))', وقت الاستعلام: 0.48s تنقيح النتائج
  1. 141

    Top 50 results of a commercial kinase screen using [γ<sup>33</sup>]-ATP and human obscurin SH3-DH as substrates. حسب Daniel Koch (388049)

    منشور في 2023
    "…A value >3 is considered a significant hit. B, validation experiment with same method of top 3 hits in screening assay at different substrate concentrations and n = 3 replicates per concentration (** p < 0.01, *** p < 0.001, students t-test vs no kinase condition). …"
  2. 142

    Diabetic kidney shows decreased klotho expression. حسب Jeong Suk Kang (7359572)

    منشور في 2021
    "…<p>(a) Representative images of the kidney from normal and diabetic biopsies showing the decreased klotho expression in diabetic podocytes by IHC. …"
  3. 143
  4. 144

    The relative difference between the target dose of plan S<sub>50</sub> and base plan (n حسب Huaqu Zeng (20601563)

    منشور في 2025
    "…</b> Among the 21 patients in plan S<sub>50</sub>, only one showed a decrease in target dose exceeding 2% but remaining below 2.5% compared to the base plan. …"
  5. 145
  6. 146
  7. 147
  8. 148

    Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma حسب Zhihao Liu (419349)

    منشور في 2024
    "…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"
  9. 149

    Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma حسب Zhihao Liu (419349)

    منشور في 2024
    "…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"
  10. 150

    Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma حسب Zhihao Liu (419349)

    منشور في 2024
    "…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"
  11. 151
  12. 152
  13. 153
  14. 154

    2‑Aminobenzoxazole Derivatives as Potent Inhibitors of the Sphingosine-1-Phosphate Transporter Spinster Homolog 2 (Spns2) حسب Ariel L. Burgio (15069256)

    منشور في 2023
    "…Our studies revealed <b>SLB1122168</b> (<b>33p</b>), which is a potent inhibitor (IC<sub>50</sub> = 94 ± 6 nM) of Spns2-mediated S1P release. …"
  15. 155

    Juvenile demyelination leads to a decrease in axonal complexity of PFC PV interneurons. حسب Sara Hijazi (21656615)

    منشور في 2025
    "…<b>F</b>. Example image of a biocytin-labeled PFC PV interneuron from a control mouse (left) and from cuprizone-treated mouse (right); scale bar: 50 µm. …"
  16. 156

    mTORC1 hyperactivation led to a decreased autophagic activity in the podocytes. حسب Wakiko Iwata (8600457)

    منشور في 2020
    "…(<b>B</b>) <i>FIP200</i> and <i>ATG101</i> mRNA expressions were decreased in the primary cultured podocytes from <i>Tsc2</i><sup>Δ<i>podocyte</i></sup>. …"
  17. 157

    Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. حسب Djaloul Karboua (16510091)

    منشور في 2023
    "…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…"
  18. 158

    N2142A mutation reduced viral replication and binding to cell by impairing receptor binding. حسب Xue Li (285380)

    منشور في 2023
    "…<b>(C)</b> The fraction #10 samples of CVA10-WT and CVA10-N142A were diluted to 50 μg/ml and subjected to negative stain electron microscopy. …"
  19. 159

    Scatter plot for the absolute decrease in CS rates (A) and the relative decrease in CS rates (B) from 2008 to 2016 among hospitals in Guangzhou grouped by their baseline CS rates. حسب Xiaoyan Xia (560153)

    منشور في 2019
    "…One circle represents one hospital, with blue (<i>n</i> = 20), green (<i>n</i> = 36), orange (<i>n</i> = 34), and purple (<i>n</i> = 22) representing baseline CS rates of <30%, 30%–39%, 40%–49%, and ≥50%, respectively. …"
  20. 160